PMC:3220857 / 1141-1512 JSONTXT

{"target":"http://pubannotation.org/docs/sourcedb/PMC/sourceid/3220857","sourcedb":"PMC","sourceid":"3220857","source_url":"https://www.ncbi.nlm.nih.gov/pmc/3220857","text":"A 16-week VLCD markedly decreased plasma CETP concentration (−18%; P \u003c 0.01) and increased plasma apolipoprotein (apo)AI levels (+16%; P \u003c 0.05), without significantly affecting plasma HDL-cholesterol and HDL-phospholipids. Although a VLCD results in HDL that is less lipidated, the functionality of HDL with respect to inducing cholesterol efflux in vitro was unchanged.","tracks":[]}